Charles River Laboratories Announces Third-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Charles River Labs (CRL) PT Raised to $147 at RBC Capital
November 8, 2018 7:01 AM ESTRBC Capital analyst George Hill raised the price target on Charles River Labs (NYSE: CRL) to $147.00 (from $131.00) while maintaining an Outperform rating following Q3 results, which beat on EPS and revenue though margin missed.
"We believe the miss was largely a... More
Charles River Laboratories (CRL) Tops Q3 EPS by 15c
November 7, 2018 7:03 AM ESTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.53, $0.15 better than the analyst estimate of $1.38. Revenue for the quarter came in at $585.3 million versus the consensus estimate of $567.79 million.
GUIDANCE:
Charles River Laboratories sees FY2018 EPS of $5.87-$5.97, versus the... More
